company background image
6472 logo

Bora Pharmaceuticals TWSE:6472 Stock Report

Last Price

NT$876.00

Market Cap

NT$88.1b

7D

-2.7%

1Y

26.6%

Updated

26 Jul, 2024

Data

Company Financials +

Bora Pharmaceuticals Co., LTD.

TWSE:6472 Stock Report

Market Cap: NT$88.1b

6472 Stock Overview

Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.

6472 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance4/6
Financial Health5/6
Dividends2/6

Bora Pharmaceuticals Co., LTD. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bora Pharmaceuticals
Historical stock prices
Current Share PriceNT$876.00
52 Week HighNT$975.00
52 Week LowNT$548.00
Beta0.72
11 Month Change8.82%
3 Month Change16.49%
1 Year Change26.57%
33 Year Change463.45%
5 Year Change1,192.35%
Change since IPO1,847.88%

Recent News & Updates

Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Jul 18
Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Recent updates

Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Jul 18
Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Shareholder Returns

6472TW PharmaceuticalsTW Market
7D-2.7%-1.5%-3.2%
1Y26.6%12.4%26.7%

Return vs Industry: 6472 exceeded the TW Pharmaceuticals industry which returned 13.6% over the past year.

Return vs Market: 6472 underperformed the TW Market which returned 31.2% over the past year.

Price Volatility

Is 6472's price volatile compared to industry and market?
6472 volatility
6472 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement4.4%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 6472 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6472's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007n/aBobby Shengwww.bora-corp.com

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments.

Bora Pharmaceuticals Co., LTD. Fundamentals Summary

How do Bora Pharmaceuticals's earnings and revenue compare to its market cap?
6472 fundamental statistics
Market capNT$88.14b
Earnings (TTM)NT$2.71b
Revenue (TTM)NT$12.28b

32.6x

P/E Ratio

7.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6472 income statement (TTM)
RevenueNT$12.28b
Cost of RevenueNT$5.71b
Gross ProfitNT$6.57b
Other ExpensesNT$3.86b
EarningsNT$2.71b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)26.90
Gross Margin53.53%
Net Profit Margin22.05%
Debt/Equity Ratio71.5%

How did 6472 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

45%

Payout Ratio

Does 6472 pay a reliable dividends?

See 6472 dividend history and benchmarks
When do you need to buy 6472 by to receive an upcoming dividend?
Bora Pharmaceuticals dividend dates
Ex Dividend DateAug 12 2024
Dividend Pay DateAug 30 2024
Days until Ex dividend15 days
Days until Dividend pay date33 days

Does 6472 pay a reliable dividends?

See 6472 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.